“Hepatocarcinoma in HBV infection is controlled by the use of entecavir, interferon and tenofovir: viral suppression and restoration of hepatic decompensation”, Acervo Científico, vol. 47, p. e16415, May 2024, doi: 10.25248/reac.e16415.2024.